| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 贸易(元) | 2,847,966,184.51 | 1,287,384,632.54 | 2,305,502,969.38 | 1,085,680,760.88 |
| 原药(元) | 7,315,287,175.95 | 3,655,204,935.67 | 6,418,379,590.58 | 3,323,392,931.78 |
| 制剂(元) | 1,497,614,521.15 | 1,170,533,448.58 | 1,545,410,058.34 | 1,203,844,377.31 |
| 其他(元) | 517,377.35 | 120,398,078.92 | 341,509.44 | 85,782,251.58 |
| 营业成本(元) | ||||
| 贸易(元) | 2,640,925,163.01 | 1,182,175,833.84 | 2,136,536,361.22 | 1,009,128,617.36 |
| 原药(元) | 5,379,999,020.15 | 2,624,033,162.32 | 4,640,229,351.54 | 2,345,247,396.61 |
| 制剂(元) | 1,053,460,929.44 | 858,084,859.57 | 1,085,268,630.49 | 894,169,541.14 |
| 其他(元) | - | 95,851,727.78 | - | 69,419,174.46 |
| 毛利(元) | ||||
| 贸易(元) | 207,041,021.50 | 105,208,798.70 | 168,966,608.16 | 76,552,143.52 |
| 原药(元) | 1,935,288,155.80 | 1,031,171,773.35 | 1,778,150,239.04 | 978,145,535.17 |
| 制剂(元) | 444,153,591.71 | 312,448,589.01 | 460,141,427.85 | 309,674,836.17 |
| 其他(元) | 517,377.35 | 24,546,351.14 | 341,509.44 | 16,363,077.12 |
| 毛利率(%) | ||||
| 贸易(%) | 7.27 | 8.17 | 7.33 | 7.05 |
| 原药(%) | 26.46 | 28.21 | 27.70 | 29.43 |
| 制剂(%) | 29.66 | 26.69 | 29.77 | 25.72 |
| 其他(%) | - | 20.39 | - | 19.08 |
| 收入构成(%) | ||||
| 贸易(%) | 24.42 | 20.65 | 22.45 | 19.05 |
| 原药(%) | 62.73 | 58.64 | 62.50 | 58.32 |
| 制剂(%) | 12.84 | 18.78 | 15.05 | 21.12 |
| 其他(%) | 0.00 | 1.93 | 0.00 | 1.51 |
| 毛利构成(%) | ||||
| 贸易(%) | 8.00 | 7.14 | 7.02 | 5.54 |
| 原药(%) | 74.81 | 69.99 | 73.86 | 70.84 |
| 制剂(%) | 17.17 | 21.21 | 19.11 | 22.43 |
| 其他(%) | 0.02 | 1.67 | 0.01 | 1.19 |